✦ LIBER ✦

Molecular mechanism of interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease

✍ Scribed by Peterson, R.L.; Wang, L.; Albert, L.M.; Keith, J.C.; Dorner, A.J.

Book ID: 122760035
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 161 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)84313-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomic analysis of rhIL-11 trea

Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease

✍ Peterson, R L; Wang, L; Albert, L; Marchese, E; Erickson, J; Wong, A; Mounts, W 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 398 KB

Cellular and Molecular Mechanisms in the

Cellular and Molecular Mechanisms in the Two Major Forms of Inflammatory Bowel Disease

✍ Laszlo Bene; Andras Falus; Noemi Baffy; Andras Kristof Fulop 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 257 KB

Oral delivery of recombinant human inter

Oral delivery of recombinant human interleukin-11 decreases clinical signs and histologic lesions in animal models of inflammatory bowel disease

✍ Carl Keith, James; Albert, Leo; Marchese, Erik; Tseng, Leo C-M; McCarthy, Kyle; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

P305 - The molecular mechanism of action

P305 - The molecular mechanism of action of anti-TNF antibodies in inflammatory bowel diseases

✍ R. Atreya; M. Zimmer; B. Bartsch; M.F. Neurath 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 112 KB

S1728 The Molecular Mechanism of Action

S1728 The Molecular Mechanism of Action of Clinically Effective Anti-TNF Antibodies in Inflammatory Bowel Diseases

✍ Atreya, Raja N.; Zimmer, Michael; Bartsch, Brigitte; Galle, Peter R.; Neurath, M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Mechanism of the uricosuric action of th

Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia

✍ Harumi Yamada; Hajime Kotaki; Hisao Furitsu; Yasufumi Sawada; Tatsuji Iga 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

E3040, a new class of anti-inflammatory drug, was found to reduce the plasma uric acid level in the first phase of clinical studies. In the present study, the mechanism of the uricosuric action of E3040 was investigated using the hyperuricemia model rat. The fractional excretion of uric acid (FE ura